Profil
Serge Messerlian is Chief Executive Officer at Creyon Bio, Inc. starting in 2025 and Operating Partner at DCVC Management Co. LLC since 2024.
Former roles include Chief Executive Officer at Janssen Oncology, Inc., Aragon Pharmaceuticals, Inc., and Chief Executive Officer & Director at Teon Therapeutics, Inc. Education includes undergraduate and graduate degrees from McGill University and an MBA from the University of Toronto.
Aktive Positionen von Serge Messerlian
| Unternehmen | Position | Beginn |
|---|---|---|
DCVC Management Co. LLC
DCVC Management Co. LLC Investment ManagersFinance DCVC invests in companies located in the United states and Europe. The firm target companies operating mainly in the deep technology sector. It provides financing for seed, early, and later stage capital requirements. It also participates in subsequent rounds. | Private Equity Investor | 01.01.2024 |
Creyon Bio, Inc.
Creyon Bio, Inc. BiotechnologyHealth Technology Develops nucleic acid drugs | Vorstandsvorsitzender | 01.08.2024 |
Ehemalige bekannte Positionen von Serge Messerlian
| Unternehmen | Position | Ende |
|---|---|---|
Teon Therapeutics, Inc.
Teon Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovering and developing molecule drugs for cancer immunotherapy, cardiovascular and metabolic diseases | Vorstandsvorsitzender | - |
Aragon Pharmaceuticals, Inc.
Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Vorstandsvorsitzender | - |
Janssen Oncology, Inc.
Janssen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer | Vorstandsvorsitzender | - |
Ausbildung von Serge Messerlian
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
McGill University
McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aragon Pharmaceuticals, Inc.
Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Janssen Oncology, Inc.
Janssen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer | Health Technology |
DCVC Management Co. LLC
DCVC Management Co. LLC Investment ManagersFinance DCVC invests in companies located in the United states and Europe. The firm target companies operating mainly in the deep technology sector. It provides financing for seed, early, and later stage capital requirements. It also participates in subsequent rounds. | Finance |
Teon Therapeutics, Inc.
Teon Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovering and developing molecule drugs for cancer immunotherapy, cardiovascular and metabolic diseases | Commercial Services |
Creyon Bio, Inc.
Creyon Bio, Inc. BiotechnologyHealth Technology Develops nucleic acid drugs | Health Technology |
















